Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group
- PMID: 1731438
- DOI: 10.1046/j.1537-2995.1992.32192116435.x
Blood loss and replacement in total hip arthroplasty: a multicenter study. The Preoperative Autologous Blood Donation Study Group
Abstract
To determine blood loss, the number of transfusions, and the hemoglobin levels achieved in patients via transfusion in the course of total hip arthroplasty, 324 patient records from 1987 through 1989 were reviewed at three university and three community hospitals. Calculated blood loss was 3.2 +/- 1.3 units in primary procedures and 4.0 +/- 2.1 units in revision procedures (mean +/- SD). Of 777 red cell units transfused, 455 (59%) were autologous units. Transfused patients received 2.0 +/- 1.8 units for primary procedures and 2.9 +/- 2.3 units for revision procedures (mean +/- SD). The maximum number of units given to 95 percent of the transfused patients was 4 for primary procedures and 6 for revision procedures. The mean postoperative hemoglobin level after all transfusions was 103 to 110 g per L, regardless of patient age group of physical status, autologous donor status, or hospital. No difference in length of hospital stay was observed for patients less than 65 years old with hemoglobin concentrations of 80 to 139 g per L at discharge.
Similar articles
-
Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion.J Bone Joint Surg Am. 2000 Jan;82(1):89-100. doi: 10.2106/00004623-200001000-00011. J Bone Joint Surg Am. 2000. PMID: 10653088
-
An analysis of blood management in patients having a total hip or knee arthroplasty.J Bone Joint Surg Am. 1999 Jan;81(1):2-10. doi: 10.2106/00004623-199901000-00002. J Bone Joint Surg Am. 1999. PMID: 9973048
-
Patient blood management in elective total hip- and knee-replacement surgery (part 2): a randomized controlled trial on blood salvage as transfusion alternative using a restrictive transfusion policy in patients with a preoperative hemoglobin above 13 g/dl.Anesthesiology. 2014 Apr;120(4):852-60. doi: 10.1097/ALN.0000000000000135. Anesthesiology. 2014. PMID: 24434302 Clinical Trial.
-
Relationship of hemoglobin level and duration of hospitalization after total hip arthroplasty: implications for the transfusion target.Mayo Clin Proc. 1993 Jan;68(1):37-41. doi: 10.1016/s0025-6196(12)60016-0. Mayo Clin Proc. 1993. PMID: 8417252
-
[Short donation intervals in preoperative autologous blood donation in the concept of autologous transfusion].Anaesthesist. 1994 Jan;43(1):9-15. doi: 10.1007/pl00013235. Anaesthesist. 1994. PMID: 8122728 Clinical Trial. German.
Cited by
-
Bipolar sealer not superior to standard electrocautery in primary total hip arthroplasty: a meta-analysis.J Orthop Surg Res. 2014 Oct 10;9:92. doi: 10.1186/s13018-014-0092-5. J Orthop Surg Res. 2014. PMID: 25300445 Free PMC article.
-
Tranexamic acid for the prevention and management of orthopedic surgical hemorrhage: current evidence.J Blood Med. 2015 Aug 25;6:239-44. doi: 10.2147/JBM.S61915. eCollection 2015. J Blood Med. 2015. PMID: 26345147 Free PMC article. Review.
-
The clinical efficacy of using autologous platelet rich plasma in hip arthroplasty: A retrospective comparative study.J Nat Sci Biol Med. 2015 Jan-Jun;6(1):49-55. doi: 10.4103/0976-9668.149077. J Nat Sci Biol Med. 2015. PMID: 25810634 Free PMC article.
-
Comparison of oral and intravenous tranexamic acid in total hip arthroplasty: a systematic review and meta-analysis.Arthroplasty. 2020 Apr 8;2(1):9. doi: 10.1186/s42836-020-00027-7. Arthroplasty. 2020. PMID: 35236425 Free PMC article.
-
Determinants of allogeneic transfusion among patients who had an autologous blood procedure, France.Eur J Epidemiol. 2004;19(4):329-33. doi: 10.1023/b:ejep.0000024694.05415.f3. Eur J Epidemiol. 2004. PMID: 15180103
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical